BRAF and cutaneous melanoma: Unlike cutaneous melanoma, mucosal melanoma shows BRAF mutations less frequently (10–15%), and these are more commonly non-V600E/K mutations [23], limiting the applicability of results from the COMBI-AD trial to this group.